These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7866806)

  • 1. Effect of sulglycotide in the prevention of duodenal ulcer relapse.
    De Conca V; Saccomanno S; Dodero M; Aste H
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):25-8. PubMed ID: 7866806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study].
    Ciaco A; Papi C; Capurso L
    Minerva Gastroenterol Dietol; 1992; 38(3):153-9. PubMed ID: 1363719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
    Ocaña Andrade E; Porras Katz JC; Beltrán Escobar G; Jáuregui Garduño JL
    Rev Gastroenterol Mex; 1997; 62(2):94-7. PubMed ID: 9471669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse prevention of duodenal ulcers with trimipramine, cimetidine, or placebo. A double-blind comparison.
    Becker U; Faurschou P; Jensen J; Lindorff K; Pedersen PB; Ranløv PJ
    Scand J Gastroenterol; 1984 May; 19(3):405-10. PubMed ID: 6377466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of duodenal ulcer relapse by cimetidine: a one-year double-blind trial.
    Hetzel DJ; Shearman DJ; Hecker R; Sheers R
    Med J Aust; 1979 Jun; 1(11):529-31. PubMed ID: 381873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Ardizzone S
    Scand J Gastroenterol; 1993 Oct; 28(10):875-8. PubMed ID: 8266016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study.
    Classen M; Bethge H; Brunner G; Dirr B; Frotz H; Gabor M; Gail H; Grabner R; Hagenmüller F; Heinkel K
    Scand J Gastroenterol Suppl; 1983; 83():61-8. PubMed ID: 6356323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance treatment of recurrent duodenal ulceration with pirenzepine.
    Petrillo M; Bianchi Porro G
    Hepatogastroenterology; 1980 Oct; 27(5):369-71. PubMed ID: 7009360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
    Bytzer P; Teglbjaerg PS;
    Am J Gastroenterol; 2001 May; 96(5):1409-16. PubMed ID: 11374675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G
    Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind placebo-controlled evaluation of one year therapy with sucralfate in healed duodenal ulcer.
    Moshal MG; Spitaels JM; Manion GL
    Scand J Gastroenterol Suppl; 1983; 83():57-9. PubMed ID: 6356322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal behaviour of healed duodenal ulcer.
    Gupta AK; Pal LS
    J Indian Med Assoc; 1998 Apr; 96(4):106-8. PubMed ID: 9844330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
    Lazzaroni M; Perego M; Bargiggia S; Maconi G; Fiocca R; Solcia E; Franceschi M; Cesana B; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):220-7. PubMed ID: 9646213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of duodenal ulcer with pirenzepine. A double-blind, placebo-controlled trial.
    Dal Monte PR; Bianchi Porro G; Petrillo M; Giuliani-Piccari G; D'Imperio N; Daniotti S
    Scand J Gastroenterol Suppl; 1982; 72():225-8. PubMed ID: 6753116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
    Bianchi Porro G; Lazzaroni M; Bargiggia S; Maconi G; Trespi E; Perego M; Alvisi C; Villani L; Luinetti O; Fiocca R; Franceschi M; Cesana B; Solcia E
    Am J Gastroenterol; 1996 Apr; 91(4):695-700. PubMed ID: 8677931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial.
    Fallone CA; Loo V; Joseph L; Barkun J; Kostyk R; Barkun AN
    Clin Invest Med; 1999 Oct; 22(5):185-94. PubMed ID: 10579057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.